Titre :

Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities.

Auteur(s) :

Pinquier, Didier [Auteur]
Cancer and Brain Genomics [CBG]
Crépey, Pascal [Auteur]
Recherche sur les services et le management en santé [RSMS]
Arènes: politique, santé publique, environnement, médias [ARENES]
École des Hautes Études en Santé Publique [EHESP] [EHESP]
Tissières, Pierre [Auteur]
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
Centre National de la Recherche Scientifique [CNRS]
Vabret, Astrid [Auteur]
Dynamique Microbienne associée aux Infections Urinaires et Respiratoires [DYNAMICURE]
Roze, Jean-Christophe [Auteur]
Physiopathologie des Adaptations Nutritionnelles [PhAN]
Dubos, Francois [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Cahn-Sellem, Fabienne [Auteur]
Association Française de Pédiatrie Ambulatoire [AFPA]
Javouhey, Etienne [Auteur]
Hospices Civils de Lyon [HCL]
Cohen, Robert [Auteur]
Association Française de Pédiatrie Ambulatoire [AFPA]
Weil-Olivier, Catherine [Auteur]
Université Paris Diderot - Paris 7 [UPD7]

Titre de la revue :

Infectious Diseases and Therapy

Nom court de la revue :

Infect Dis Ther

Pagination :

1-16

Date de publication :

2022-12-24

ISSN :

2193-8229

Mot(s)-clé(s) en anglais :

Children
France
Immunisation
Infants
Nirsevimab
Palivizumab
Pharmacoeconomics
Primary healthcare
Public health
Respiratory syncytial virus

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

The highly contagious respiratory syncytial virus (RSV) is responsible for up to approximately 50,000 hospitalisations during each RSV season in children aged under 5 years in France, with the burden greatest in infants ...
Lire la suite >The highly contagious respiratory syncytial virus (RSV) is responsible for up to approximately 50,000 hospitalisations during each RSV season in children aged under 5 years in France, with the burden greatest in infants younger than 1 year who were born at term. There is a need for a strategy to universally protect young children from RSV infection, and thereby reduce the pressure that RSV places every year on RSV-infected children, their parents, and French healthcare systems. Potential strategies currently undergoing clinical investigation include passive immunisation via maternal vaccination or administration of long-acting monoclonal antibodies at or soon after birth, followed by vaccination later in infancy or childhood. An ongoing partnership and collaboration between parents, public health authorities, and frontline primary healthcare will need to be reinforced once these new RSV prevention strategies are available, to facilitate their use and ensure that all children receive adequate protection from the start of their first RSV season.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
CHU Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Date de dépôt :

2023-11-15T02:52:15Z
2024-04-08T12:57:51Z